Breaking News Instant updates and real-time market news.

HAS

Hasbro

$89.76 /

-5.9 (-6.17%)

17:11
01/26/22
01/26
17:11
01/26/22
17:11

Hasbro price target lowered to $119 from $128 at Goldman Sachs

Goldman Sachs analyst Michael Ng lowered the firm's price target on Hasbro to $119 from $128 but keeps a Buy rating on the shares. The loss of Disney Princess and Frozen franchise license will impact the company's profitability, but Lucasfilm relationship extension is encouraging, the analyst tells investors in a research note. Ng adds that his reduced price target also models lower target multiple of 21-times expected earnings vs. 22-times prior and reflects compression in the market multiple.

  • 07

    Feb

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Athersys downgraded to Neutral from Buy at BofA » 06:53
05/23/22
05/23
06:53
05/23/22
06:53
ATHX

Athersys

/

+

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATHX Athersys
/

+

ATHX Athersys
/

+

11/19/21 BofA
Athersys downgraded to Neutral from Buy at BofA (yesterday)
ATHX Athersys
/

+

ATHX Athersys
/

+

Recommendations
Public Storage price target lowered to $365 from $375 at Raymond James » 06:53
05/23/22
05/23
06:53
05/23/22
06:53
PSA

Public Storage

$313.02 /

+3.16 (+1.02%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSA Public Storage
$313.02 /

+3.16 (+1.02%)

PSA Public Storage
$313.02 /

+3.16 (+1.02%)

05/19/22 BMO Capital
Public Storage upgraded to Outperform from Market Perform at BMO Capital
04/04/22 JPMorgan
Public Storage price target raised to $434 from $385 at JPMorgan
01/18/22 Truist
Public Storage price target raised to $380 from $353 at Truist
01/10/22 Jefferies
Public Storage upgraded to Buy from Hold at Jefferies
PSA Public Storage
$313.02 /

+3.16 (+1.02%)

PSA Public Storage
$313.02 /

+3.16 (+1.02%)

PSA Public Storage
$313.02 /

+3.16 (+1.02%)

Upgrade
Credit Suisse upgrades DTE Energy to Outperform, lowers price target to $140 » 06:52
05/23/22
05/23
06:52
05/23/22
06:52
DTE

DTE Energy

$128.68 /

-0.27 (-0.21%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTE DTE Energy
$128.68 /

-0.27 (-0.21%)

DTE DTE Energy
$128.68 /

-0.27 (-0.21%)

06:27 Today Credit Suisse
DTE Energy upgraded to Outperform from Neutral at Credit Suisse
05/03/22 Citi
DTE Energy price target raised to $146 from $134 at Citi
04/25/22 Credit Suisse
DTE Energy initiated with a Neutral at Credit Suisse
03/11/22 UBS
DTE Energy downgraded to Neutral from Buy at UBS
DTE DTE Energy
$128.68 /

-0.27 (-0.21%)

Upgrade
CubeSmart upgraded to Strong Buy from Outperform at Raymond James » 06:52
05/23/22
05/23
06:52
05/23/22
06:52
CUBE

CubeSmart

$40.85 /

+0.14 (+0.34%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CUBE CubeSmart
$40.85 /

+0.14 (+0.34%)

04:47 Today Raymond James
CubeSmart upgraded to Strong Buy from Outperform at Raymond James
05/16/22 Truist
CubeSmart price target lowered to $48 from $55 at Truist
04/04/22 JPMorgan
CubeSmart price target raised to $58 from $57 at JPMorgan
01/24/22 Stifel
CubeSmart called 'favorite storage name' at Stifel after management meeting
CUBE CubeSmart
$40.85 /

+0.14 (+0.34%)

  • 17
    Nov
Hot Stocks
Spire Global awarded TCOM subcontract for weather forecasts at aerostat sites » 06:52
05/23/22
05/23
06:52
05/23/22
06:52
SPIR

Spire Global

$1.44 /

-0.03 (-2.04%)

Spire Global was awarded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPIR Spire Global
$1.44 /

-0.03 (-2.04%)

SPIR Spire Global
$1.44 /

-0.03 (-2.04%)

04/21/22 Raymond James
Spire Global initiated with an Outperform at Raymond James
03/28/22 CJS Securities
Spire Global initiated with an Outperform at CJS Securities
03/03/22 Stifel
Spire Global initiated with a Buy at Stifel
01/19/22 BofA
Spire Global downgraded to Underperform at BofA on valuation
SPIR Spire Global
$1.44 /

-0.03 (-2.04%)

SPIR Spire Global
$1.44 /

-0.03 (-2.04%)

SPIR Spire Global
$1.44 /

-0.03 (-2.04%)

Downgrade
Axon assumed at Equal Weight from Overweight at Morgan Stanley » 06:50
05/23/22
05/23
06:50
05/23/22
06:50
AXON

Axon

$99.50 /

+1 (+1.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXON Axon
$99.50 /

+1 (+1.02%)

AXON Axon
$99.50 /

+1 (+1.02%)

06:42 Today Morgan Stanley
Axon downgraded to Equal Weight from Overweight at Morgan Stanley
05/16/22 Baird
Baird downgrades three cloud stocks on focus shift to cash flows
05/12/22 Northland
Axon price target lowered to $130 from $180 at Northland
05/11/22 Baird
Axon price target lowered to $125 from $145 at Baird
AXON Axon
$99.50 /

+1 (+1.02%)

AXON Axon
$99.50 /

+1 (+1.02%)

Initiation
Regeneron initiated with an Outperform at SVB Leerink » 06:50
05/23/22
05/23
06:50
05/23/22
06:50
REGN

Regeneron

$661.76 /

+3.73 (+0.57%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REGN Regeneron
$661.76 /

+3.73 (+0.57%)

REGN Regeneron
$661.76 /

+3.73 (+0.57%)

05/13/22 Piper Sandler
Atopic dermatitis market looks 'increasingly crowded,' says Piper Sandler
04/20/22 Cowen
Regeneron price target raised to $645 from $640 at Cowen
04/20/22 BTIG
Checkmate Pharmaceuticals downgraded to Neutral from Buy at BTIG
04/19/22 Baird
Decibel could be next target for Regeneron, says Baird
REGN Regeneron
$661.76 /

+3.73 (+0.57%)

REGN Regeneron
$661.76 /

+3.73 (+0.57%)

REGN Regeneron
$661.76 /

+3.73 (+0.57%)

Hot Stocks
Cable One authorizes additional share repurchase of up to $450M » 06:49
05/23/22
05/23
06:49
05/23/22
06:49
CABO

Cable One

$1,193.94 /

+17.89 (+1.52%)

Cable One has authorized…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CABO Cable One
$1,193.94 /

+17.89 (+1.52%)

CABO Cable One
$1,193.94 /

+17.89 (+1.52%)

05/06/22 Truist
Cable One price target lowered to $1,400 from $2,000 at Truist
05/06/22 KeyBanc
Cable One price target lowered to $1,896 from $2,326 at KeyBanc
05/06/22 Wells Fargo
Cable One price target lowered to $1,800 from $2,100 at Wells Fargo
04/13/22 Wells Fargo
Wells Fargo expects 'smooth' CFO transition, remains bullish on Cable One
CABO Cable One
$1,193.94 /

+17.89 (+1.52%)

Initiation
Sanofi initiated with an Outperform at SVB Leerink » 06:48
05/23/22
05/23
06:48
05/23/22
06:48
SNY

Sanofi

$54.38 /

+1.3 (+2.45%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$54.38 /

+1.3 (+2.45%)

SNY Sanofi
$54.38 /

+1.3 (+2.45%)

05/09/22 Wedbush
Wedbush downgrades Arvinas to Neutral, cuts price target to $43
05/02/22 Guggenheim
Sanofi price target raised to EUR 127 from EUR 121 at Guggenheim
04/28/22 Credit Suisse
Kymera Therapeutics initiated with an Outperform at Credit Suisse
04/26/22 Stifel
Arvinas price target lowered to $85 from $93 at Stifel
SNY Sanofi
$54.38 /

+1.3 (+2.45%)

SNY Sanofi
$54.38 /

+1.3 (+2.45%)

SNY Sanofi
$54.38 /

+1.3 (+2.45%)

Hot Stocks
Ocwen authorizes $50M share repurchase program » 06:47
05/23/22
05/23
06:47
05/23/22
06:47
OCN

Ocwen

$23.08 /

-0.59 (-2.49%)

Ocwen authorized a share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCN Ocwen
$23.08 /

-0.59 (-2.49%)

OCN Ocwen
$23.08 /

-0.59 (-2.49%)

04/20/22 BTIG
Ocwen initiated with a Neutral at BTIG
03/16/22 B. Riley
Ocwen price target lowered to $50 from $56 at B. Riley
12/08/21 B. Riley
Ocwen price target raised to $56 from $50 at B. Riley
09/09/21 B. Riley
B. Riley starts Ocwen with Buy, sees turnaround story in 'early innings'
OCN Ocwen
$23.08 /

-0.59 (-2.49%)

OCN Ocwen
$23.08 /

-0.59 (-2.49%)

Hot Stocks
Pfizer, BioNTech vaccine demonstrates strong immune response in Phase 2/3 trial » 06:47
05/23/22
05/23
06:47
05/23/22
06:47
PFE

Pfizer

$52.46 /

+1.805 (+3.56%)

, BNTX

BioNTech

$163.00 /

-4.48 (-2.67%)

Pfizer (PFE) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

06:38 Today SVB Leerink
Pfizer initiated with a Market Perform at SVB Leerink
05/11/22 H.C. Wainwright
Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright
05/11/22 Wedbush
Global Blood Therapeutics added to Best Ideas List at Wedbush
05/05/22 Stifel
Stifel keeps Buy rating on Arvinas, lowers price target to $82
BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

04/12/22 H.C. Wainwright
BioNTech price target lowered to $298 from $339 at H.C. Wainwright
04/11/22 H.C. Wainwright
H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
04/05/22 Canaccord
BioNTech price target lowered to $300 from $450 at Canaccord
02/23/22 H.C. Wainwright
BioNTech price target lowered to $336 from $366 at H.C. Wainwright
PFE Pfizer
$52.46 /

+1.805 (+3.56%)

BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

PFE Pfizer
$52.46 /

+1.805 (+3.56%)

BNTX BioNTech
$163.00 /

-4.48 (-2.67%)

Upgrade
Motorola Solutions assumed at Overweight from Equal Weight at Morgan Stanley » 06:47
05/23/22
05/23
06:47
05/23/22
06:47
MSI

Motorola Solutions

$210.37 /

-0.035 (-0.02%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

06:43 Today Morgan Stanley
Motorola Solutions upgraded to Overweight from Equal Weight at Morgan Stanley
05/09/22 Credit Suisse
Credit Suisse starts Axon at Outperform with $169 price target
05/09/22 Credit Suisse
Credit Suisse starts Tyler Technologies at Neutral with $408 price target
04/25/22 Loop Capital
Motorola Solutions initiated with a Buy at Loop Capital
MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

MSI Motorola Solutions
$210.37 /

-0.035 (-0.02%)

Downgrade
Covetrus downgraded to Market Perform from Outperform at Raymond James » 06:46
05/23/22
05/23
06:46
05/23/22
06:46
CVET

Covetrus

$19.68 /

+1.65 (+9.15%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVET Covetrus
$19.68 /

+1.65 (+9.15%)

CVET Covetrus
$19.68 /

+1.65 (+9.15%)

05/09/22 Barclays
Covetrus price target lowered to $26 from $38 at Barclays
01/12/22 Goldman Sachs
Covetrus' 2022 Rx revenue outlook may be disappointing, says Goldman Sachs
11/18/21 Morgan Stanley
Covetrus initiated with an Equal Weight at Morgan Stanley
08/04/21 Credit Suisse
Covetrus assumed with a Neutral at Credit Suisse
CVET Covetrus
$19.68 /

+1.65 (+9.15%)

CVET Covetrus
$19.68 /

+1.65 (+9.15%)

Initiation
Vertex Pharmaceuticals initiated with a Market Perform at SVB Leerink » 06:45
05/23/22
05/23
06:45
05/23/22
06:45
VRTX

Vertex Pharmaceuticals

$258.71 /

+3.265 (+1.28%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

05/06/22 Wells Fargo
Vertex Pharmaceuticals price target raised to $305 from $300 at Wells Fargo
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral at Baird after 21% advance
05/06/22 Baird
Vertex Pharmaceuticals downgraded to Neutral from Outperform at Baird
05/06/22 Piper Sandler
Vertex Pharmaceuticals price target lowered to $242 from $249 at Piper Sandler
VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

VRTX Vertex Pharmaceuticals
$258.71 /

+3.265 (+1.28%)

Recommendations
Nio could be back to pre-shutdown levels by June, says Mizuho » 06:45
05/23/22
05/23
06:45
05/23/22
06:45
NIO

Nio

$16.44 /

-0.23 (-1.38%)

, TSLA

Tesla

$664.10 /

-45.39 (-6.40%)

Mizuho analyst Vijay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

05/16/22 BofA
Nio upgraded to Buy at BofA on 'brighter' second half view
05/16/22 BofA
Nio upgraded to Buy from Neutral at BofA
05/02/22 Morgan Stanley
Nio's April sales 'crimped' by lockdowns, says Morgan Stanley
04/13/22 Nomura
Nio production halt limited to weekends, says Nomura
TSLA Tesla
$664.10 /

-45.39 (-6.40%)

05/19/22 Wedbush
Tesla price target lowered to $1,000 from $1,400 at Wedbush
05/18/22 Exane BNP Paribas
Tesla gets price target cut after losing Exane's 'EV World Cup'
05/18/22 Piper Sandler
Tesla price target lowered to $1,035 from $1,260 at Piper Sandler
05/17/22 Tudor Pickering
Tesla upgraded to Hold from Sell at Tudor Pickering
NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

NIO Nio
$16.44 /

-0.23 (-1.38%)

TSLA Tesla
$664.10 /

-45.39 (-6.40%)

Upgrade
Trimble upgraded to Equal Weight from Underweight at Morgan Stanley » 06:43
05/23/22
05/23
06:43
05/23/22
06:43
TRMB

Trimble

$65.24 /

+0.16 (+0.25%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRMB Trimble
$65.24 /

+0.16 (+0.25%)

TRMB Trimble
$65.24 /

+0.16 (+0.25%)

05/06/22 Baird
Trimble price target lowered to $80 from $90 at Baird
03/28/22 JPMorgan
Trimble price target lowered to $77 from $79 at JPMorgan
10/14/21 Piper Sandler
Trimble initiated with Overweight on digitization at Piper Sandler
10/14/21 Piper Sandler
Trimble initiated with an Overweight at Piper Sandler
TRMB Trimble
$65.24 /

+0.16 (+0.25%)

Initiation
Theravance Biopharma initiated with an Outperform at SVB Leerink » 06:43
05/23/22
05/23
06:43
05/23/22
06:43
TBPH

Theravance Biopharma

$8.74 /

-0.09 (-1.02%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

02/24/22 H.C. Wainwright
Theravance Biopharma price target raised to $12 from $8 at H.C. Wainwright
11/05/21 JPMorgan
Theravance Biopharma upgraded to Neutral from Underweight at JPMorgan
09/16/21 Baird
Theravance Biopharma price target lowered to $7 from $10 at Baird
09/16/21 H.C. Wainwright
Theravance price target lowered to $8 from $21 at H.C. Wainwright
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

  • 25
    Jun
TBPH Theravance Biopharma
$8.74 /

-0.09 (-1.02%)

Initiation
Roivant Sciences initiated with an Outperform at SVB Leerink » 06:42
05/23/22
05/23
06:42
05/23/22
06:42
ROIV

Roivant Sciences

$3.72 /

+0.075 (+2.06%)

SVB Leerink analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

04/29/22 Cantor Fitzgerald
Roivant Sciences initiated with an Overweight at Cantor Fitzgerald
12/15/21 Goldman Sachs
Roivant Sciences initiated with a Buy at Goldman Sachs
12/02/21 H.C. Wainwright
H.C. Wainwright says Arbutus patent win may mean 'considerable gain' for Roivant
11/08/21 H.C. Wainwright
Roivant Sciences initiated with a Buy at H.C. Wainwright
ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

ROIV Roivant Sciences
$3.72 /

+0.075 (+2.06%)

Conference/Events
United Fire Group management to meet with Piper Sandler » 06:42
05/23/22
05/23
06:42
05/23/22
06:42
UFCS

United Fire Group

$29.42 /

-1.13 (-3.70%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

03/21/22 Piper Sandler
United Fire Group price target raised to $37 from $30 at Piper Sandler
12/01/21 Piper Sandler
United Fire Group upgraded to Overweight from Neutral at Piper Sandler
07/09/21 Piper Sandler
United Fire Group price target lowered to $28 from $35 at Piper Sandler
06/28/21 Sidoti
United Fire Group upgraded to Buy from Neutral at Sidoti
UFCS United Fire Group
$29.42 /

-1.13 (-3.70%)

Upgrade
Zebra Technologies upgraded to Equal Weight from Underweight at Morgan Stanley » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
ZBRA

Zebra Technologies

$325.57 /

+0.995 (+0.31%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

05/04/22 Needham
Zebra Technologies price target lowered to $500 from $535 at Needham
05/04/22 Baird
Zebra Technologies price target lowered to $440 from $550 at Baird
04/12/22 Morgan Stanley
Morgan Stanley cuts Telecom & Networking Equipment industry view to Cautious
04/12/22 Morgan Stanley
Zebra Technologies price target lowered to $400 from $470 at Morgan Stanley
ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

ZBRA Zebra Technologies
$325.57 /

+0.995 (+0.31%)

Initiation
Alteryx initiated with an Outperform at FBN Securities » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
AYX

Alteryx

$55.68 /

+0.16 (+0.29%)

FBN Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

05/04/22 Loop Capital
Alteryx price target raised to $67 from $60 at Loop Capital
05/04/22 Cowen
Alteryx price target raised to $90 from $75 at Cowen
05/04/22 Citi
Alteryx price target raised to $95 from $86 at Citi
04/01/22 Needham
Alteryx price target raised to $86 from $66 at Needham
AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

AYX Alteryx
$55.68 /

+0.16 (+0.29%)

Recommendations
April delinquency trends promising for Affirm, says Mizuho » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
AFRM

Affirm

/

+

Mizuho analyst Dan Dolev…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AFRM Affirm
/

+

AFRM Affirm
/

+

05/17/22 Mizuho
Affirm price target lowered to $50 from $79 at Mizuho
05/16/22 Barclays
Affirm price target lowered to $35 from $65 at Barclays
05/13/22 RBC Capital
Affirm price target lowered to $48 from $58 at RBC Capital
05/13/22 Morgan Stanley
Affirm results reassuring, investors likely still cautious, says Morgan Stanley
AFRM Affirm
/

+

AFRM Affirm
/

+

AFRM Affirm
/

+

AFRM Affirm
/

+

Downgrade
Frontdoor downgraded to Hold from Buy at Truist » 06:41
05/23/22
05/23
06:41
05/23/22
06:41
FTDR

Frontdoor

$26.45 /

+0.245 (+0.94%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

05/06/22 Truist
Frontdoor price target lowered to $32 from $50 at Truist
05/06/22 Raymond James
Frontdoor price target lowered to $31 from $40 at Raymond James
05/06/22 Oppenheimer
Frontdoor price target lowered to $34 from $41 at Oppenheimer
01/06/22 Goldman Sachs
Frontdoor assumed with a Neutral at Goldman Sachs
FTDR Frontdoor
$26.45 /

+0.245 (+0.94%)

Conference/Events
Timken management to meet with Loop Capital » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
TKR

Timken

$57.88 /

-0.735 (-1.25%)

Meetings to be held in CA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TKR Timken
$57.88 /

-0.735 (-1.25%)

TKR Timken
$57.88 /

-0.735 (-1.25%)

05/03/22 KeyBanc
Timken price target lowered to $75 from $84 at KeyBanc
04/13/22 Oppenheimer
Timken initiated with an Outperform at Oppenheimer
02/15/22 Evercore ISI
Timken upgraded to Outperform at Evercore ISI on relative valuation
02/15/22 Evercore ISI
Oshkosh downgraded to In Line at Evercore ISI on relative valuation
TKR Timken
$57.88 /

-0.735 (-1.25%)

Upgrade
TreeHouse upgraded to Buy from Hold at Truist » 06:40
05/23/22
05/23
06:40
05/23/22
06:40
THS

TreeHouse

/

+

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THS TreeHouse
/

+

THS TreeHouse
/

+

03/22/22 Truist
TreeHouse price target lowered to $35 from $40 at Truist
THS TreeHouse
/

+

THS TreeHouse
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.